21 CFR 830.200
§ 830.200 When FDA will act as an issuing agency.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 830.200, § 830.200 When FDA will act as an issuing agency, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/88979
- Permanent ID
ys:prov:88979@1- SHA-256
882a318d33c6bfb282d1272fc3d66566982dc19acf1d76576d2ab5b1924aaf3c
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) During any period where there is no accredited issuing agency, FDA will act as an issuing agency.
(b) If FDA determines that a significant number of small businesses would be substantially and adversely affected by the fees required by all accredited issuing agencies, FDA will act as an issuing agency.
(c) FDA may, in its discretion, act as an issuing agency if we determine it is necessary for us to do so to ensure the continuity or the effectiveness of the system for the identification of medical devices.
(d) FDA may, in its discretion, act as an issuing agency if we determine it is appropriate for us to do so in order to facilitate or implement an alternative granted under § 801.55 of this chapter.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.